ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Menomune-A & C & Y & W-135 Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-6J12441
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Menomune A C Y W 135 Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Menomune-A & C & Y & W-135 Market Research Report 2024

Code: QYRE-Auto-6J12441
Report
January 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur
GSK
Hualan Bio
Walvax
Kanghua Bio
Beijing Luzhu Biopharmaceutical

Menomune-A & C & Y & W-135 Market Size

The global Menomune-A & C & Y & W-135 market was valued at US$ 1354 million in 2023 and is anticipated to reach US$ 1802.2 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.

Menomune-A & C & Y & W-135 Market

Menomune-A & C & Y & W-135 Market

Menomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Menomune-A & C & Y & W-135, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menomune-A & C & Y & W-135.

Report Scope

The Menomune-A & C & Y & W-135 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Menomune-A & C & Y & W-135 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Menomune-A & C & Y & W-135 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Menomune-A & C & Y & W-135 Market Report

Report Metric Details
Report Name Menomune-A & C & Y & W-135 Market
Accounted market size in 2023 US$ 1354 million
Forecasted market size in 2030 US$ 1802.2 million
CAGR 4.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Oligosaccharide
  • Polysaccharide
Segment by Application
  • Public
  • Private
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, GSK, Hualan Bio, Beijing Luzhu Biopharmaceutical, Walvax, Kanghua Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Menomune-A & C & Y & W-135 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Menomune-A & C & Y & W-135 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Menomune-A & C & Y & W-135 Market growing?

Ans: The Menomune-A & C & Y & W-135 Market witnessing a CAGR of 4.2% during the forecast period 2024-2030.

What is the Menomune-A & C & Y & W-135 Market size in 2030?

Ans: The Menomune-A & C & Y & W-135 Market size in 2030 will be US$ 1802.2 million.

Who are the main players in the Menomune-A & C & Y & W-135 Market report?

Ans: The main players in the Menomune-A & C & Y & W-135 Market are Sanofi Pasteur, GSK, Hualan Bio, Beijing Luzhu Biopharmaceutical, Walvax, Kanghua Bio

What are the Application segmentation covered in the Menomune-A & C & Y & W-135 Market report?

Ans: The Applications covered in the Menomune-A & C & Y & W-135 Market report are Public, Private

What are the Type segmentation covered in the Menomune-A & C & Y & W-135 Market report?

Ans: The Types covered in the Menomune-A & C & Y & W-135 Market report are Oligosaccharide, Polysaccharide

1 Menomune-A & C & Y & W-135 Market Overview
1.1 Product Overview and Scope of Menomune-A & C & Y & W-135
1.2 Menomune-A & C & Y & W-135 Segment by Type
1.2.1 Global Menomune-A & C & Y & W-135 Market Value Comparison by Type (2024-2030)
1.2.2 Oligosaccharide
1.2.3 Polysaccharide
1.3 Menomune-A & C & Y & W-135 Segment by Application
1.3.1 Global Menomune-A & C & Y & W-135 Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Menomune-A & C & Y & W-135 Market Size Estimates and Forecasts
1.4.1 Global Menomune-A & C & Y & W-135 Revenue 2019-2030
1.4.2 Global Menomune-A & C & Y & W-135 Sales 2019-2030
1.4.3 Global Menomune-A & C & Y & W-135 Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Menomune-A & C & Y & W-135 Market Competition by Manufacturers
2.1 Global Menomune-A & C & Y & W-135 Sales Market Share by Manufacturers (2019-2024)
2.2 Global Menomune-A & C & Y & W-135 Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Menomune-A & C & Y & W-135 Average Price by Manufacturers (2019-2024)
2.4 Global Menomune-A & C & Y & W-135 Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Menomune-A & C & Y & W-135, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Menomune-A & C & Y & W-135, Product Type & Application
2.7 Menomune-A & C & Y & W-135 Market Competitive Situation and Trends
2.7.1 Menomune-A & C & Y & W-135 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Menomune-A & C & Y & W-135 Players Market Share by Revenue
2.7.3 Global Menomune-A & C & Y & W-135 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Menomune-A & C & Y & W-135 Retrospective Market Scenario by Region
3.1 Global Menomune-A & C & Y & W-135 Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Menomune-A & C & Y & W-135 Global Menomune-A & C & Y & W-135 Sales by Region: 2019-2030
3.2.1 Global Menomune-A & C & Y & W-135 Sales by Region: 2019-2024
3.2.2 Global Menomune-A & C & Y & W-135 Sales by Region: 2025-2030
3.3 Global Menomune-A & C & Y & W-135 Global Menomune-A & C & Y & W-135 Revenue by Region: 2019-2030
3.3.1 Global Menomune-A & C & Y & W-135 Revenue by Region: 2019-2024
3.3.2 Global Menomune-A & C & Y & W-135 Revenue by Region: 2025-2030
3.4 North America Menomune-A & C & Y & W-135 Market Facts & Figures by Country
3.4.1 North America Menomune-A & C & Y & W-135 Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Menomune-A & C & Y & W-135 Sales by Country (2019-2030)
3.4.3 North America Menomune-A & C & Y & W-135 Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Menomune-A & C & Y & W-135 Market Facts & Figures by Country
3.5.1 Europe Menomune-A & C & Y & W-135 Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Menomune-A & C & Y & W-135 Sales by Country (2019-2030)
3.5.3 Europe Menomune-A & C & Y & W-135 Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Menomune-A & C & Y & W-135 Market Facts & Figures by Country
3.6.1 Asia Pacific Menomune-A & C & Y & W-135 Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Menomune-A & C & Y & W-135 Sales by Country (2019-2030)
3.6.3 Asia Pacific Menomune-A & C & Y & W-135 Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Menomune-A & C & Y & W-135 Market Facts & Figures by Country
3.7.1 Latin America Menomune-A & C & Y & W-135 Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Menomune-A & C & Y & W-135 Sales by Country (2019-2030)
3.7.3 Latin America Menomune-A & C & Y & W-135 Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Menomune-A & C & Y & W-135 Market Facts & Figures by Country
3.8.1 Middle East and Africa Menomune-A & C & Y & W-135 Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Menomune-A & C & Y & W-135 Sales by Country (2019-2030)
3.8.3 Middle East and Africa Menomune-A & C & Y & W-135 Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Menomune-A & C & Y & W-135 Sales by Type (2019-2030)
4.1.1 Global Menomune-A & C & Y & W-135 Sales by Type (2019-2024)
4.1.2 Global Menomune-A & C & Y & W-135 Sales by Type (2025-2030)
4.1.3 Global Menomune-A & C & Y & W-135 Sales Market Share by Type (2019-2030)
4.2 Global Menomune-A & C & Y & W-135 Revenue by Type (2019-2030)
4.2.1 Global Menomune-A & C & Y & W-135 Revenue by Type (2019-2024)
4.2.2 Global Menomune-A & C & Y & W-135 Revenue by Type (2025-2030)
4.2.3 Global Menomune-A & C & Y & W-135 Revenue Market Share by Type (2019-2030)
4.3 Global Menomune-A & C & Y & W-135 Price by Type (2019-2030)
5 Segment by Application
5.1 Global Menomune-A & C & Y & W-135 Sales by Application (2019-2030)
5.1.1 Global Menomune-A & C & Y & W-135 Sales by Application (2019-2024)
5.1.2 Global Menomune-A & C & Y & W-135 Sales by Application (2025-2030)
5.1.3 Global Menomune-A & C & Y & W-135 Sales Market Share by Application (2019-2030)
5.2 Global Menomune-A & C & Y & W-135 Revenue by Application (2019-2030)
5.2.1 Global Menomune-A & C & Y & W-135 Revenue by Application (2019-2024)
5.2.2 Global Menomune-A & C & Y & W-135 Revenue by Application (2025-2030)
5.2.3 Global Menomune-A & C & Y & W-135 Revenue Market Share by Application (2019-2030)
5.3 Global Menomune-A & C & Y & W-135 Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Menomune-A & C & Y & W-135 Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Menomune-A & C & Y & W-135 Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Hualan Bio
6.3.1 Hualan Bio Corporation Information
6.3.2 Hualan Bio Description and Business Overview
6.3.3 Hualan Bio Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hualan Bio Menomune-A & C & Y & W-135 Product Portfolio
6.3.5 Hualan Bio Recent Developments/Updates
6.4 Beijing Luzhu Biopharmaceutical
6.4.1 Beijing Luzhu Biopharmaceutical Corporation Information
6.4.2 Beijing Luzhu Biopharmaceutical Description and Business Overview
6.4.3 Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Product Portfolio
6.4.5 Beijing Luzhu Biopharmaceutical Recent Developments/Updates
6.5 Walvax
6.5.1 Walvax Corporation Information
6.5.2 Walvax Description and Business Overview
6.5.3 Walvax Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Walvax Menomune-A & C & Y & W-135 Product Portfolio
6.5.5 Walvax Recent Developments/Updates
6.6 Kanghua Bio
6.6.1 Kanghua Bio Corporation Information
6.6.2 Kanghua Bio Description and Business Overview
6.6.3 Kanghua Bio Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kanghua Bio Menomune-A & C & Y & W-135 Product Portfolio
6.6.5 Kanghua Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Menomune-A & C & Y & W-135 Industry Chain Analysis
7.2 Menomune-A & C & Y & W-135 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Menomune-A & C & Y & W-135 Production Mode & Process
7.4 Menomune-A & C & Y & W-135 Sales and Marketing
7.4.1 Menomune-A & C & Y & W-135 Sales Channels
7.4.2 Menomune-A & C & Y & W-135 Distributors
7.5 Menomune-A & C & Y & W-135 Customers
8 Menomune-A & C & Y & W-135 Market Dynamics
8.1 Menomune-A & C & Y & W-135 Industry Trends
8.2 Menomune-A & C & Y & W-135 Market Drivers
8.3 Menomune-A & C & Y & W-135 Market Challenges
8.4 Menomune-A & C & Y & W-135 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Pasteur
GSK
Hualan Bio
Walvax
Kanghua Bio
Beijing Luzhu Biopharmaceutical
List of Tables
    Table 1. Global Menomune-A & C & Y & W-135 Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Menomune-A & C & Y & W-135 Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Menomune-A & C & Y & W-135 Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Menomune-A & C & Y & W-135 Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Menomune-A & C & Y & W-135 Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Menomune-A & C & Y & W-135 Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Menomune-A & C & Y & W-135 Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Menomune-A & C & Y & W-135 Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Menomune-A & C & Y & W-135, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Menomune-A & C & Y & W-135, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Menomune-A & C & Y & W-135, Product Type & Application
    Table 12. Global Key Manufacturers of Menomune-A & C & Y & W-135, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Menomune-A & C & Y & W-135 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menomune-A & C & Y & W-135 as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Menomune-A & C & Y & W-135 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Menomune-A & C & Y & W-135 Sales by Region (2019-2024) & (K Units)
    Table 18. Global Menomune-A & C & Y & W-135 Sales Market Share by Region (2019-2024)
    Table 19. Global Menomune-A & C & Y & W-135 Sales by Region (2025-2030) & (K Units)
    Table 20. Global Menomune-A & C & Y & W-135 Sales Market Share by Region (2025-2030)
    Table 21. Global Menomune-A & C & Y & W-135 Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Menomune-A & C & Y & W-135 Revenue Market Share by Region (2019-2024)
    Table 23. Global Menomune-A & C & Y & W-135 Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Menomune-A & C & Y & W-135 Revenue Market Share by Region (2025-2030)
    Table 25. North America Menomune-A & C & Y & W-135 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Menomune-A & C & Y & W-135 Sales by Country (2019-2024) & (K Units)
    Table 27. North America Menomune-A & C & Y & W-135 Sales by Country (2025-2030) & (K Units)
    Table 28. North America Menomune-A & C & Y & W-135 Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Menomune-A & C & Y & W-135 Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Menomune-A & C & Y & W-135 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Menomune-A & C & Y & W-135 Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Menomune-A & C & Y & W-135 Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Menomune-A & C & Y & W-135 Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Menomune-A & C & Y & W-135 Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Menomune-A & C & Y & W-135 Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Menomune-A & C & Y & W-135 Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Menomune-A & C & Y & W-135 Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Menomune-A & C & Y & W-135 Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Menomune-A & C & Y & W-135 Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Menomune-A & C & Y & W-135 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Menomune-A & C & Y & W-135 Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Menomune-A & C & Y & W-135 Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Menomune-A & C & Y & W-135 Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Menomune-A & C & Y & W-135 Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Menomune-A & C & Y & W-135 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Menomune-A & C & Y & W-135 Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Menomune-A & C & Y & W-135 Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Menomune-A & C & Y & W-135 Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Menomune-A & C & Y & W-135 Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Menomune-A & C & Y & W-135 Sales (K Units) by Type (2019-2024)
    Table 51. Global Menomune-A & C & Y & W-135 Sales (K Units) by Type (2025-2030)
    Table 52. Global Menomune-A & C & Y & W-135 Sales Market Share by Type (2019-2024)
    Table 53. Global Menomune-A & C & Y & W-135 Sales Market Share by Type (2025-2030)
    Table 54. Global Menomune-A & C & Y & W-135 Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Menomune-A & C & Y & W-135 Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Menomune-A & C & Y & W-135 Revenue Market Share by Type (2019-2024)
    Table 57. Global Menomune-A & C & Y & W-135 Revenue Market Share by Type (2025-2030)
    Table 58. Global Menomune-A & C & Y & W-135 Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Menomune-A & C & Y & W-135 Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Menomune-A & C & Y & W-135 Sales (K Units) by Application (2019-2024)
    Table 61. Global Menomune-A & C & Y & W-135 Sales (K Units) by Application (2025-2030)
    Table 62. Global Menomune-A & C & Y & W-135 Sales Market Share by Application (2019-2024)
    Table 63. Global Menomune-A & C & Y & W-135 Sales Market Share by Application (2025-2030)
    Table 64. Global Menomune-A & C & Y & W-135 Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Menomune-A & C & Y & W-135 Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Menomune-A & C & Y & W-135 Revenue Market Share by Application (2019-2024)
    Table 67. Global Menomune-A & C & Y & W-135 Revenue Market Share by Application (2025-2030)
    Table 68. Global Menomune-A & C & Y & W-135 Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Menomune-A & C & Y & W-135 Price (USD/Unit) by Application (2025-2030)
    Table 70. Sanofi Pasteur Corporation Information
    Table 71. Sanofi Pasteur Description and Business Overview
    Table 72. Sanofi Pasteur Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Sanofi Pasteur Menomune-A & C & Y & W-135 Product
    Table 74. Sanofi Pasteur Recent Developments/Updates
    Table 75. GSK Corporation Information
    Table 76. GSK Description and Business Overview
    Table 77. GSK Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. GSK Menomune-A & C & Y & W-135 Product
    Table 79. GSK Recent Developments/Updates
    Table 80. Hualan Bio Corporation Information
    Table 81. Hualan Bio Description and Business Overview
    Table 82. Hualan Bio Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Hualan Bio Menomune-A & C & Y & W-135 Product
    Table 84. Hualan Bio Recent Developments/Updates
    Table 85. Beijing Luzhu Biopharmaceutical Corporation Information
    Table 86. Beijing Luzhu Biopharmaceutical Description and Business Overview
    Table 87. Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Product
    Table 89. Beijing Luzhu Biopharmaceutical Recent Developments/Updates
    Table 90. Walvax Corporation Information
    Table 91. Walvax Description and Business Overview
    Table 92. Walvax Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Walvax Menomune-A & C & Y & W-135 Product
    Table 94. Walvax Recent Developments/Updates
    Table 95. Kanghua Bio Corporation Information
    Table 96. Kanghua Bio Description and Business Overview
    Table 97. Kanghua Bio Menomune-A & C & Y & W-135 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Kanghua Bio Menomune-A & C & Y & W-135 Product
    Table 99. Kanghua Bio Recent Developments/Updates
    Table 100. Key Raw Materials Lists
    Table 101. Raw Materials Key Suppliers Lists
    Table 102. Menomune-A & C & Y & W-135 Distributors List
    Table 103. Menomune-A & C & Y & W-135 Customers List
    Table 104. Menomune-A & C & Y & W-135 Market Trends
    Table 105. Menomune-A & C & Y & W-135 Market Drivers
    Table 106. Menomune-A & C & Y & W-135 Market Challenges
    Table 107. Menomune-A & C & Y & W-135 Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Menomune-A & C & Y & W-135
    Figure 2. Global Menomune-A & C & Y & W-135 Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Menomune-A & C & Y & W-135 Market Share by Type in 2023 & 2030
    Figure 4. Oligosaccharide Product Picture
    Figure 5. Polysaccharide Product Picture
    Figure 6. Global Menomune-A & C & Y & W-135 Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Menomune-A & C & Y & W-135 Market Share by Application in 2023 & 2030
    Figure 8. Public
    Figure 9. Private
    Figure 10. Global Menomune-A & C & Y & W-135 Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Menomune-A & C & Y & W-135 Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Menomune-A & C & Y & W-135 Sales (2019-2030) & (K Units)
    Figure 13. Global Menomune-A & C & Y & W-135 Average Price (USD/Unit) & (2019-2030)
    Figure 14. Menomune-A & C & Y & W-135 Report Years Considered
    Figure 15. Menomune-A & C & Y & W-135 Sales Share by Manufacturers in 2023
    Figure 16. Global Menomune-A & C & Y & W-135 Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Menomune-A & C & Y & W-135 Players: Market Share by Revenue in 2023
    Figure 18. Menomune-A & C & Y & W-135 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Menomune-A & C & Y & W-135 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Menomune-A & C & Y & W-135 Sales Market Share by Country (2019-2030)
    Figure 21. North America Menomune-A & C & Y & W-135 Revenue Market Share by Country (2019-2030)
    Figure 22. the United States Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Menomune-A & C & Y & W-135 Sales Market Share by Country (2019-2030)
    Figure 25. Europe Menomune-A & C & Y & W-135 Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. UK Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Menomune-A & C & Y & W-135 Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Menomune-A & C & Y & W-135 Revenue Market Share by Region (2019-2030)
    Figure 33. China Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Menomune-A & C & Y & W-135 Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Menomune-A & C & Y & W-135 Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Menomune-A & C & Y & W-135 Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Menomune-A & C & Y & W-135 Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Menomune-A & C & Y & W-135 Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Menomune-A & C & Y & W-135 by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Menomune-A & C & Y & W-135 by Type (2019-2030)
    Figure 54. Global Menomune-A & C & Y & W-135 Price (USD/Unit) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Menomune-A & C & Y & W-135 by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Menomune-A & C & Y & W-135 by Application (2019-2030)
    Figure 57. Global Menomune-A & C & Y & W-135 Price (USD/Unit) by Application (2019-2030)
    Figure 58. Menomune-A & C & Y & W-135 Value Chain
    Figure 59. Menomune-A & C & Y & W-135 Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions